Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.6B |
| 2 |
Broadcom
AVGO
|
+$1.11B |
| 3 |
Invesco QQQ Trust
QQQ
|
+$882M |
| 4 |
JPMorgan Chase
JPM
|
+$628M |
| 5 |
Tesla
TSLA
|
+$594M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$1.54B |
| 2 |
Visa
V
|
+$1.39B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.13B |
| 4 |
Amazon
AMZN
|
+$771M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$575M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.83% |
| 2 | Financials | 7.37% |
| 3 | Consumer Discretionary | 6.6% |
| 4 | Communication Services | 5.05% |
| 5 | Healthcare | 4.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRP.U
3751
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $444K | ﹤0.01% |
8,763
-28,622
| -77% | -$1.36M |
|
3752
CALL
Travere Therapeutics
TVTX
$5.79B
| $444K | ﹤0.01% |
+30,000
| New | +$497K |
|
3753
Krispy Kreme
DNUT
$569M
| $441K | ﹤0.01% |
151,547
-17,864
| -11% | -$62.4K |
|
|
KGEI
3754
Kolibri Global Energy
KGEI
$200M
| $441K | ﹤0.01% |
64,363
+46,651
| +263% | +$321K |
|
3755
Citizens Financial Services
CZFS
$393M
| $440K | ﹤0.01% |
7,500
+2,784
| +59% | +$160K |
|
3756
Editas Medicine
EDIT
$432M
| $439K | ﹤0.01% |
199,530
+58,346
| +41% | +$95.5K |
|
|
EFSI
3757
Eagle Financial Services Inc
EFSI
$234M
| $438K | ﹤0.01% |
+14,292
| New | +$442K |
|
3758
Entravision Communication
EVC
$820M
| $437K | ﹤0.01% |
188,415
+43,083
| +30% | +$86.9K |
|
3759
Rayonier Advanced Materials
RYAM
$570M
| $436K | ﹤0.01% |
113,248
+43,472
| +62% | +$183K |
|
3760
Precigen
PGEN
$2.32B
| $435K | ﹤0.01% |
306,418
+126,583
| +70% | +$180K |
|
3761
Limoneira
LMNR
$250M
| $435K | ﹤0.01% |
27,795
+11,138
| +67% | +$176K |
|
|
TECX
3762
Tectonic Therapeutic
TECX
$664M
| $435K | ﹤0.01% |
21,891
+8,181
| +60% | +$166K |
|
|
ZIMV
3763
DELISTED
ZimVie
ZIMV
| $434K | ﹤0.01% |
46,413
+18,439
| +66% | +$168K |
|
3764
Abeona Therapeutics
ABEO
$361M
| $434K | ﹤0.01% |
76,401
-8,364
| -10% | -$47.6K |
|
3765
Satellogic
SATL
$906M
| $434K | ﹤0.01% |
+119,875
| New | +$452K |
|
3766
TFS Financial
TFSL
$4.93B
| $434K | ﹤0.01% |
33,503
+6,132
| +22% | +$79K |
|
|
BRT
3767
BRT Apartments
BRT
$269M
| $434K | ﹤0.01% |
27,733
+16,278
| +142% | +$256K |
|
|
KWY
3768
Kingsway Corp
KWY
$283M
| $434K | ﹤0.01% |
32,034
+18,253
| +132% | +$194K |
|
3769
CALL
AMC Entertainment Holdings
AMC
$2.35B
| $430K | ﹤0.01% |
138,700
| – | – |
|
3770
United States Natural Gas Fund
UNG
$489M
| $430K | ﹤0.01% |
28,118
+17,153
| +156% | +$296K |
|
3771
Aura Biosciences
AURA
$791M
| $429K | ﹤0.01% |
68,551
+18,156
| +36% | +$106K |
|
3772
Gencor Industries
GENC
$264M
| $428K | ﹤0.01% |
30,607
+9,146
| +43% | +$120K |
|
3773
The Joint Corp
JYNT
$119M
| $428K | ﹤0.01% |
37,046
+15,083
| +69% | +$161K |
|
3774
Rocket Pharmaceuticals
RCKT
$367M
| $427K | ﹤0.01% |
174,438
+7,556
| +5% | +$38.3K |
|
3775
First Community Corp
FCCO
$325M
| $427K | ﹤0.01% |
17,528
+4,579
| +35% | +$105K |
|
Similar funds
Barclays's Q2 2025 Portfolio in Review
As of Q2 2025, Barclays held 5,681 positions worth $436B, up 24% from $353B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Barclays deployed $35.4B of net new capital in Q2 2025, opening 461 new positions and adding to 2,914 existing holdings. Its largest new stake was iShares MBS ETF: 4,310,047 shares worth $405M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Honeywell, an estimated $1.54B trimmed.
- Barclays's largest Q2 2025 buy was iShares MBS ETF: 4,310,047 shares worth $405M.
- Barclays added most to NVIDIA in Q2 2025, an estimated $1.6B increase.
- Barclays's biggest Q2 2025 reduction was Honeywell, cutting an estimated $1.54B.
- Barclays fully exited Berry Global Group, Inc. in Q2 2025, selling an estimated $173M.
- Barclays's ten largest holdings make up 43% of its $436B portfolio in Q2 2025.
- Barclays opened 461 new positions and closed 463 in Q2 2025.
- Barclays's portfolio value rose 24% quarter-over-quarter to $436B.
Based on Barclays's 13F filing for Q2 2025, filed 13 Aug 2025.